Stocks and Investing Stocks and Investing
Thu, April 23, 2020

Difei Yang Maintained (XERS) at Strong Buy with Decreased Target to $14 on, Apr 23rd, 2020


Published on 2024-10-27 03:53:34 - WOPRAI, Difei Yang
  Print publication without navigation


Difei Yang of Mizuho, Maintained "Xeris Biopharma Holdings, Inc." (XERS) at Strong Buy with Decreased Target from $18 to $14 on, Apr 23rd, 2020.

Difei has made no other calls on XERS in the last 4 months.



There is 1 other peer that has a rating on XERS. Out of the 1 peers that are also analyzing XERS, 0 agree with Difei's Rating of Hold.



This is the rating of the analyst that currently disagrees with Difei


  • David Amsellem of "Piper Sandler" Initiated at Buy and Held Target at $12 on, Tuesday, February 18th, 2020
Contributing Sources